Participation of an abnormality in the transforming growth factor-β signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor

Journal of Neurosurgery

Volumn 105, Issue 1, 2006, Pages 119-128

  Zhang, Lei ^a   Sato, Eiji ^a   Amagasaki, Kenichi ^a   Nakao, Atsuhito ^a   Naganuma, Hirofumi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Malignant glioma; p21; Ski; Smad; SnoN; Transforming growth factor

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P15; PROTEIN P21; PROTEIN SKI; PROTEIN SNON; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL GROWTH; CONTROLLED STUDY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL CULTURE TECHNIQUES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GLIOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 33745532884     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.1.119     Document Type: Article

References (48)

1. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, et al: c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J Biol Chem 274:35269-35277, 1999
2. Alexandrow MG, Moses HL: Kips off to Myc: implications for TGF-β signaling. J Cell Biochem 66:427-432, 1997
3. Attisano L, Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 12:235-243, 2000
4. Cerutti JM, Ebina KN, Matsuo SE, Martins L, Maciel RM, Kimura ET: Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines. J Endocrinol Invest 26:516-521, 2003
5. Colmenares C, Sutrave P, Hughes SH, Stavnezer E: Activation of the c-ski oncogene by overexpression. J Virol 65:4929-4935, 1991
6. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF: Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol Cell Biol 19:2495-504, 1999
7. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A 92:5545-5549, 1995
8. Datto MB, Yu Y, Wang XF: Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628, 1995
9. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM: TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020, 1993
10. Feng XH, Lin X, Derynck R: Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-β. EMBO J 19:5178-5193, 2000
11. Fuxe J, Akusjarvi G, Goike HM, Roos G, Collins VP, Pettersson RF: Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ 11:373-384, 2000
12. Han SU, Kim HT, Seong do H, Kim YS, Park YS, Bang YJ, et al: Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23:1333-1341, 2004
13. Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261, 1994
14. Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K: The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J Cell Biol 155:1017-1027, 2001
15. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al: The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173, 1997
16. Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
17. Hu PP, Datto MB, Wang XF: Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev 19:349-363, 1998
18. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, et al: Smad6 inhibits signalling by the TGF-β superfamily. Nature 389:622-626, 1997
19. Isoe S, Naganuma H, Nakano S, Sasaki A, Satoh E, Nagasaka M, et al: Resistance to growth inhibition by transforming growth factor-β in malignant glioma cells with functional receptors. J Neurosurg 88:529-534, 1998
20. Itoh S, Landstrom M, Hermansson A, Itoh F, Heldin CH, Heldin NE, et al: Transforming growth factor β 1 induces nuclear export of inhibitory Smad7. J Biol Chem 273:29195-29201, 1998
21. Kawataki T, Naganuma H, Sasaki A, Yoshikawa H, Tasaka K, Nukui H: Correlation of thrombospondin-1 and transforming growth factor-β expression with malignancy of glioma. Neuropathology 20:161-169, 2000
22. Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, et al: Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol 15:574-580, 2004
23. Kjellman C, Olofsson SP, Hansson O, Von Schantz T, Lindvall M, Nilsson I, et al: Expression of TGF-β isoforms, TGF-β receptors, and SMAD molecules at different stages of human glioma. Int J Cancer 89:251-258, 2000
24. Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Buchler MW, et al: The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18:5363-5372, 1999
25. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD: Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10:177-184, 1995
26. Kornmann M, Tangvoranuntakul P, Korc M: TGF-β-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-β receptor. Int J Cancer 83:247-254, 1999
27. Li CY, Suardet L, Little JB: Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 270:4971-4974, 1995
28. Massague J: TGF-β signal transduction. Annu Rev Biochem 67:753-791, 1998
29. Mithani SK, Balch GC, Shiou SR, Whitehead RH, Datta PK, Beauchamp RD: Smad3 has a critical role in TGF-β-mediated growth inhibition and apoptosis in colonic epithelial cells. J Surg Res 117:296-305, 2004
30. Miyazono K: TGF-β/SMAD signaling and its involvement in tumor progression. Biol Pharm Bull 23:1125-1130, 2000
31. Moustakas A, Kardassis D: Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci U S A 95:6733-6738, 1998
32. Naganuma H, Sasaki A, Satoh E, Sakihama T, Tasaka K, Nukui H: Improved bioassay for the detection of transforming growth factor-β1 and β2 in malignant gliomas. Neurol Med Chir (Tokyo) 34:143-149, 1994
33. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al: Identification of Smad7, a TGF β-inducible antagonist of TGF-β signalling. Nature 389:631-635, 1997
34. Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R: Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res 17:5489-5500, 1989
35. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A: Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J Biol Chem 275:29244-29256, 2000
36. Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, et al: Transforming growth factor β signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 62:2778-2790, 2002
37. Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C: Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-β. Hepatogastroenterology 51:396-400, 2004
38. Pearson-White S: SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res 21:4632-4638, 1993
39. Pearson-White S, Crittenden R: Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. Nucleic Acids Res 25:2930-2937, 1997
40. Piek E, Westermark U, Kastemar M, Heldin CH, van Zoelen EJ, Nister M, et al: Expression of transforming-growth-factor (TGF)-β receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-β1. Int J Cancer 80:756-763, 1999
41. Reynisdottir I, Polyak K, Iavarone A, Massague J: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831-1845, 1995
42. Rich JN, Zhang M, Datto MB, Bigner DD, Wang XF: Transforming growth factor-β′-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem 274:35053-35058, 1999
43. Sasaki A, Naganuma H, Satoh E, Kawataki T, Amagasaki K, Nukui H: Participation of thrombospondin-1 in the activation of latent transforming growth factor-β in malignant glioma cells. Neurol Med Chir (Tokyo) 41:253-259, 2001
44. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K: Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771-774, 1999
45. Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA: Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol Cell 4:499-509, 1999
46. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA: SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc Natl Acad Sci U S A 96:12442-12447, 1999
47. Vogel G: A new blocker for the TGF-β pathway. Science 286:665, 1999
48. Zhang L, Yamane T, Satoh E, Amagasaki K, Kawataki T, Asahara T, et al: Establishment and partial characterization of five malignant glioma cell lines. Neuropathology 25:136-143, 2005